TrialMolecular therapy : the journal of the American Society of Gene Therapy2024

Case study of CD19 CAR T therapy in a subject with immune-mediate necrotizing myopathy treated in the RESET-Myositis phase I/II trial.

Jenell Volkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.